Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SARS-CoV-2 M pro protease variants of concern display altered viral and host target processing but retain potency towards antivirals

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.28.525917Source: DataRank Database

SARS-CoV-2 M pro protease variants of concern display altered viral and host target processing but retain potency towards antivirals is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (24)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Elena Arutyunova ORCID,Jimmy Lu ORCID,Muhammad Bashir Khan ORCID,Wioletta Rut ORCID,Mikołaj Żmudziński ORCID

Live enrichment

PubMed:23304386 OpenAlex:https://openalex.org/W4318453049

Natural Sciences and Engineering Research Council of Canada

Grant: unidentified

unidentified

National Institutes of Health

Grant: 3P30GM133894-06S1

A Synchrotron Radiation Structural Biology Resource

green

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/01/29/2023.01.28.525917.full.pdf

GREENhttps://doi.org/10.1101/2023.01.28.525917

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/01/29/2023.01.28.525917.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.01.28.525917

Fields of Study

Galectins and Cancer BiologyCancer Mechanisms and TherapyToxin Mechanisms and ImmunotoxinsBiologyMedicineChemistry0301 basic medicine03 medical and health sciences

Keywords

ProteasePotencyProteolysisMutantViral replicationBiologyVirulenceVirologyMutationCleavage (geology)SecretionVirusBiochemistryIn vitroGeneEnzyme

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

SARS-CoV-2 M pro protease variants of concern display altered viral and host target processing but retain potency towards antivirals

FAIR Checklist

Authors (19)

Funding (2 grants)

Open Access

Topics

Annotations (Europe PMC)